Despite growing awareness, many people still hold misconceptions about how hepatitis is transmitted and its effects. These ...
Zacks Investment Research on MSN
GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow
Gilead Sciences, Inc. GILD posted better-than-expected third-quarter 2025 results and lifted the lower end of its product ...
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious ...
Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
SVF Vaccines AB, a portfolio company of Karolinska Development AB, has presented positive results from a preclinical study of its immunotherapy SVF-001 targeting chronic hepatitis B (HBV) and D ...
TipRanks on MSN
Karolinska Development’s SVF Vaccines Shows Promising Preclinical Results for Hepatitis Treatment
An announcement from Karolinska Development AB ( ($SE:KDEV) ) is now available. Karolinska Development AB’s portfolio company, SVF Vaccines, has ...
Proposals to remove the CDC's recommendation for the Hepatitis B vaccine at birth are causing concern. The vaccine has reduced newborn infections from as many as 20,000 per year to fewer than 20. An ...
The hepatitis B vaccine, discovered and developed in Philadelphia, was recently challenged by the Trump administration. Local advocates and patients are concerned for its future.
ABSTRACT: Introduction: Viral hepatitis, particularly hepatitis B (HBV), remains a major public health issue, especially in low- and middle-income countries. In Burkina Faso, HBV prevalence was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results